Advanced Search

Technical Analysis for VOR - Vor Biopharma Inc.

Grade Last Price % Change Price Change
F 13.78 8.25% 1.05
VOR closed up 8.25 percent on Wednesday, July 28, 2021, on 1.23 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical VOR trend table...
Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 8.25%
Doji - Bullish? Reversal 8.25%
New 52 Week Low Weakness 8.25%
Wide Bands Range Expansion 8.25%
Down 3 Days in a Row Weakness 8.25%
Down 4 Days in a Row Weakness 8.25%
Oversold Stochastic Weakness 8.25%
Older End-of-Day Signals for VOR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 10% about 12 hours ago
Up 5% about 14 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Down 3% about 15 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Tyrosine Kinase Receptors Proteins Therapies For Cancer Haematopoiesis

Is VOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 28 The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Jul 8 Vor Biopharma teams up with Janssen Biotech to develop leukemia therapy
Jul 8 Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
Jun 30 Vor Biopharma: Targeted Therapies For Transplants
Jun 17 Vor Biopharma to build clinical manufacturing facility in Massachusetts
Jun 17 Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs
Jun 11 Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp
Jun 10 Vor to Develop Multi-Targeted CAR-Ts with Abound Bio
May 25 Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences
May 7 How Many Vor Biopharma Inc. (NASDAQ:VOR) Shares Do Institutions Own?
See more VOR news...

Indicators

Indicator Value
52 Week High 63.62
52 Week Low 12.03
Average Volume 139,017
200-Day Moving Average 0.00
50-Day Moving Average 19.02
20-Day Moving Average 16.45
10-Day Moving Average 14.28
Average True Range 1.51
ADX 21.38
+DI 17.71
-DI 30.55
Chandelier Exit (Long, 3 ATRs) 17.16
Chandelier Exit (Short, 3 ATRs) 16.56
Upper Bollinger Bands 21.43
Lower Bollinger Band 11.46
Percent B (%b) 0.23
BandWidth 60.61
MACD Line -1.94
MACD Signal Line -1.72
MACD Histogram -0.2247
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.72
Resistance 3 (R3) 16.53 15.36 16.23
Resistance 2 (R2) 15.36 14.61 15.46 16.07
Resistance 1 (R1) 14.57 14.15 14.97 14.76 15.90
Pivot Point 13.40 13.40 13.60 13.50 13.40
Support 1 (S1) 12.61 12.65 13.01 12.80 11.66
Support 2 (S2) 11.44 12.19 11.54 11.49
Support 3 (S3) 10.65 11.44 11.33
Support 4 (S4) 10.84